The global vascular imaging market size was valued at USD 17.5 billion in 2018 and is projected to expand at a CAGR of 4.2% by 2026. Rising prevalence of hypertension, hypercholesterolemia, and diabetes is the major factor expected to contribute towards the market growth over forecast period. These conditions increases the risk of vascular disorders such as aneurysms, carotid blockage, deep vein thrombosis and atherosclerosis; the major areas where vascular imaging devices finds application.
Increasing awareness about early diagnosis and intervention to prevent mortality or morbidity along with rising adoption of preventive healthcare techniques are the factors expected to have a significant positive impact on number of vascular imaging procedure in developed as well as developing countries. Moreover, constant technological advancement focused to provide safer diagnosis with minimum turnaround time and optimum efficiency is anticipated to play an important role in market growth over the forecast period. For instance, advance CT scanners with dual sources and sensitive detectors performs scan quickly and efficiently at low radiation exposure, thereby improving patient satisfaction.
Increasing usage of vascular imaging modalities in trauma cases along with pre, post, and intra operative procedures is anticipated to fuel the market growth during the forecast period. For instance, pre-operative coronary vascular imaging provides information suggesting whether stenting is required, whereas the post-operative vascular images provide information about the effectiveness of the cardiac grafts or stenting performed.
Increasing adoption of noninvasive diagnostic imaging techniques and rising inclination towards minimal invasive procedures and establishment of efficient clinical guidelines is expected to foster the growth over the forecast period. For instance, National Institute for Health and Care Excellence (NICE), clinical guidelines’ state the use of CT coronary angiography as first line investigation procedure for patients reporting with stable chest pain.
Based on type, the vascular imaging market is classified into minimally invasive and non-invasive. The minimally invasive market is segment into catheter angiogram, intravascular ultrasound, computed tomography angiography (CTA), lymphoscintigraphy, and venogram. Non-invasive segment is categorized into abdominal ultrasound, angiography, ankle-brachial index (ABI), captopril renal scan, carotid duplex ultrasound, CT scan, Doppler ultrasound, duplex ultrasound, MRA (magnetic resonance angiography) and MRI (magnetic resonance imaging).
Non-invasive type held the largest market share in 2018 and is expected to grow at a healthy rate over the forecast period. Higher safety, patient convenience, and shorter recovery time compared to conventional imaging procedures are the factors expected to drive the market’s growth over the forecast period. Minimally Invasive vascular imaging normally takes several hours for the catheter insertion site to get recovered, whereas, patient subjected to a coronary CT angiography can return to their routine activities immediately.
Improving specificity, sensitivity, and imaging standards coupled with optimized radiation exposure of non-invasive vascular imaging modalities is expected to boost the adoption of advanced vascular imaging modalities. According to a clinical study reported in NCBI, CT coronary angiography had a sensitivity of 80.0% and specificity of 67.0% in diagnosis of Coronary Heart Diseases (CHD), compared to 67.0% and 75.0% sensitivity and specificity respectively of conventional invasive angiography.
Based on end-use, the vascular imaging market is segmented into hospitals and diagnostics imaging center. Hospitals accounted for the largest market share in 2018, and is expected to grow at a significant rate over the forecast period. The growth of this segment is majorly contributed to the factors such as large patient pool, availability of fund to acquire advanced equipment, and high competition among healthcare service providers.
Rising number of emergency admission in hospital for condition such as stroke, chest pain and abdominal discomfort is expected to boost the demand for vascular imaging modalities in emergency departments. According to NCBI reports, acute chest pain is responsible for more than 700,000 emergency admissions every year in England and Wales. This figure is around one-fourth of all emergency admissions. This condition requires quick and accurate diagnosis to avoid complications. Introduction of handheld and quicker imaging equipment is expected to expand their applications in emergency departments including ambulatory care centers.
Diagnostics imaging centers are also expected to grow at a significant rate over the forecast period. Low cost of CT/ MRI scans, presence of diagnostics accreditation boards, and improving accessibility in developing countries such as India, China and others are the factors expected to drive the growth over the forecast period.
Based on application, the market is segmented into diagnostics and therapeutic segments. Diagnostic segment captured largest share in 2018. Introduction of advanced imaging modalities that help in reducing turnaround time and development of effective alternatives for invasive and minimally invasive diagnostic modalities are some of the major factors driving the segment growth.
Development of faster acting targeted therapies, adaption of preventive measures, and introduction of early diagnostic methods which help in increasing treatment success at early stages of disease are the factors expected to impede the growth of therapeutic segment. However, introduction of advanced technology such as vascular robots, and peripherally inserted central venous catheter is expected to resolve complications pertaining to repeat procedures and blood vessel rupture.
North America held the largest share in vascular imaging market in 2018. Presence of major players, streamlined reimbursement policies, rising incidence of stroke and prevalence of cardiovascular disorders are the factors expected to drive the growth in this region. According to AHA, 2019 heart disease and stoke statistics, on an average, every 40 seconds an American will have a stroke and about 795,000 Americans reported with new or recurrent stroke annually.
Europe accounted for the second largest market share in vascular imaging in 2019. Increasing prevalence of diabetes, obesity and cardiovascular disorders is expected to further fuel the growth. This is mainly due to rising behavioral risk factors such as smoking, alcohol consumption, unhealthy diet and sedentary lifestyle adoption. Majority of the installed units of vascular CT and MRI imaging in the region are more than 10 years old. Rapid replacement of these equipment by advanced versions is expected to boost the market dynamics in the region during the forecast period.
Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period. Developing economies with large patient pool, growing presence of international healthcare services providers, rising favorable government initiatives are some of the major factors driving the growth in the region. Major markets in the region include Japan, India, China, Thailand, and South Korea.
The players present in the market include Siemens Healthineers, GE Healthcare, Koninklijke Philips N.V. Hitachi Medical Corporation , Samsung Medisun, Shimadzu Medical Systems, Hologic Inc., Abbott Laboratories, and Carestream Health Inc. These players are focusing on adopting growth strategies, such as new product launches, innovations in the existing technologies and devices, mergers and acquisitions, partnerships, geographical expansion, and more. Recently, Siemens Healthineers completed acquisition of Corindus Vascular Robotics. This is expected to expand their portfolio of interventional vascular imaging.
GE Healthcare, one of the leading players in the industry, developed Revolution Apex, a modernized ultra-premium CT scanner. It provides features, such as enhanced visual coverage, spectral imaging options, spatial resolution, and temporal resolution, in one single system. The system is integrated with Quantix 160 Tube, a powerful tube that displays next level performance with excellent picture quality for current and new patients. Revolution Apex is also proved beneficial for patients with elevated heart rates, compromised renal function, high body mass index, and more.
Base year for estimation
Actual estimates/Historical data
2015 - 2017
2019 - 2026
Revenue in USD Million and CAGR from 2019 to 2026
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
U.S., Canada, UK, Germany, France, Italy, Spain, China, India, Japan, Thailand, South Korea Mexico, Brazil, Colombia, Argentina, South Africa, Saudi Arabia, UAE
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global vascular imaging market on the basis of type, application, end-use, and region:
Type Outlook (Revenue in USD Million, 2015 - 2026)
Ankle-brachial index (ABI)
Captopril renal scan
Carotid duplex ultrasound
MRA (magnetic resonance angiography)
MRI (magnetic resonance imaging)
Application Outlook (Revenue, SD Million, 2015 - 2026)
End-use Outlook (Revenue, USD Million; 2015 - 2026)
Diagnostic Imaging Centers
Regional Outlook (Revenue, USD Million, 2015 - 2026)
Middle East & Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.